[1] |
LI Shuran, GUO Shanshan, JI Zuen, ZHANG Wei, CUI Xiaolan.
Research status of cognitive dysfunction after SARS-CoV-2 infection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 59-64.
|
[2] |
LI Xingren, SHEN Aizong, SU Dan.
Evaluation of the rationality of proton pump inhibitors in preventing perioperative stress related mucosal disease in biliary and pancreatic surgery
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1022-1026.
|
[3] |
CHANG Yongzhuo, LI Ji, ZHANG Xiaoyan, ZHOU Chaofan.
One case of abnormal uterine bleeding caused by Baofukang suppository
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 935-938.
|
[4] |
LIU Baosheng, WANG Guanjie, WANG Zhenhua, LIU Lihong, ZHU Yan, ZHOU Xiuli.
One case of acute liver injury caused by tripterygium glycosides tablets
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 511-513.
|
[5] |
CHEN Cheng, DENG Li, LIU Songqing, DU Qian, XI Xin.
Analysis of reports of allergic shock in Chongqing between 2015 and 2020
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 460-464.
|
[6] |
LIU Baohua, SHEN Aizong, SU Dan.
Pharmaceutical care for a case of severe myelosuppression induced by meropenem injection combined with vancomycin injection
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 339-342.
|
[7] |
JIA Zhaoguang, XU Wenshuai, JI Li’na, WANG Linlin, ZHAO Li’na, ZHAO Jingquan, MU Xiangdong.
Diagnosis and treatment of mycoplasma pneumoniae pneumonia in children and rational administration of related drugs
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1391-1395.
|
[8] |
ZHANG Jingyu, ZHANG Yuanyuan, WANG Jing, MA Bo, LI Wenjuan.
Influencing factors of severe anaphylactic reactions of Yanhuning injections in children
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1019-1022.
|
[9] |
HOU Tiantian, LI Xuejiao, SUN Lei, QIN Chao, ZHAO Jing, HUO Yan, WANG Yu, GENG Xingchao, HUANG Ying.
Biodistribution study of CAR-T cells in non-bearing-tumor and tumor-bearing severe immunodeficient mice
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 823-827.
|
[10] |
ZHUANG Hongyan, ZANG Yannan, LIU Shanshan, NIU Mengxi, FANG Meng, YIN Dongqing, GUO Wei.
Analysis of neuropsychiatric adverse reactions caused by zolpidem
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 889-892.
|
[11] |
XU Zhe, JU Ping, LUO Qi, YANG Huan, WANG Yang.
930 cases of adverse drug reactions induced by antibacterial drugs in children
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 317-321.
|
[12] |
ZHANG Yongheng, HAN Chen, YANG Xiao, HAN Xiuqi, YUAN Hongchang, DENG Zhijian.
Analysis of 313 Instructions for Injectable Drugs
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 669-673.
|
[13] |
XI Yuling, HUI Hongyan, GUO Xiaohe, DENG Zhijian.
Literature Analysis of Anaphylactic Shock Induced by Reduced Glutathione for Injection
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 674-677.
|
[14] |
ZHAO Shuang, MIAO Qiuli, SONG Yanqing, LI Yue.
Hypothyroidism Caused by Terepril and Literature Analysis
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 697-699.
|
[15] |
LI Yaolei, ZHANG Bing, ZHANG Xiaomeng, LIN Zhijian.
Evaluation and Consideration of Clinical Safety of Traditional Chinese Medicine Based on Toxic Components
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(6): 520-524.
|